The latest study which was carried out by the researchers at Plymouth University, National Institute of Health and University of California has revealed the ability of a Vaccine Vector based on a common hypervirus called cytomegalovirus expressing Ebola Virus glycoprotein, to provide protection against Ebola virus.

Hypesvirus-based Vaccine can be made to produce their targeted protein in different times following Vaccination.
This research also increased the production of antibodies against Ebola Virus with no detectable Ebola-Specific Cells and is a step forward not just for Ebola virus Vaccine for use in humans but for the development of such self disseminating vaccine against other infectious and non infectious diseases.

No Comments

Leave a Comment